{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=46412L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=46412L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=4207L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4207L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4207L,Language='DE')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4207L,Language='DE')/Subjects"}},"ID":"4207","Language":"DE","MeetingNumber":11,"IdSession":5018,"SessionNumber":18,"SessionName":"Sommersession 2019","Council":1,"CouncilName":"Nationalrat","CouncilAbbreviation":"NR","Date":"\/Date(1560729600000)\/","Begin":"1430","Modified":"\/Date(1562754680947)\/","LegislativePeriodNumber":50,"PublicationStatus":"final","MeetingOrderText":"Elfte Sitzung","SortOrder":11,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20195339,IdSubject=46412L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20195339,IdSubject=46412L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20195339,IdSubject=46412L,Language='DE')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20195339,IdSubject=46412L,Language='DE')/Businesses"}},"IdSubject":"46412","BusinessNumber":20195339,"Language":"DE","BusinessShortNumber":"19.5339","Title":"Fehlende Zulassung von Kindermedikation","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1560524562256)\/","TitleDE":"Fragestunde.\nFrage Herzog Verena.\nFehlende Zulassung\nvon Kindermedikation","TitleFR":"Heure des questions.\nQuestion Herzog Verena.\nAbsence d'autorisations pour\nles m\u00e9dicaments utilis\u00e9s en p\u00e9diatrie","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=247353L,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=247353L,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=247353L,Language='DE')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=247353L,Language='DE')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=247353L,Language='DE')/Businesses"}},"ID":"247353","Language":"DE","IdSubject":"46412","VoteId":null,"PersonNumber":1161,"Type":1,"Text":"<pd_text><p>Der Bundesrat ist sich der Problematik bewusst und hat entsprechende Massnahmen ergriffen. So beinhaltet das am 1. Januar 2019 in Kraft getretene revidierte Heilmittelgesetz \u00e4hnliche Bestimmungen zur F\u00f6rderung der Entwicklung von Kinderarzneimitteln, wie sie die EU seit mehreren Jahren kennt und wie sie sich in der EU auch bew\u00e4hrt haben. Neue Arzneimittel m\u00fcssen nun [PAGE 1126] von Anfang an so entwickelt werden, dass sie auch bei Kindern und Jugendlichen sicher angewendet werden k\u00f6nnen. Dazu m\u00fcssen Pharmafirmen beispielsweise kindergerechte Darreichungsformen entwickeln und auch klinische Studien mit Kindern durchf\u00fchren. Um die Firmen f\u00fcr die besonderen Aufwendungen zur Entwicklung von Arzneimitteln f\u00fcr Kinder zu entsch\u00e4digen, gibt es neu patentrechtliche und finanzielle Anreize. Die Zulassungsinhaberin kann beim Institut f\u00fcr geistiges Eigentum eine Verl\u00e4ngerung des Patentschutzes beantragen. Im Weiteren gew\u00e4hrt Swissmedic neu f\u00fcr Arzneimittel mit rein p\u00e4diatrischer Anwendung einen Unterlagenschutz von zehn Jahren. Zudem ist die Zulassung durch Swissmedic f\u00fcr solche Arzneimittel kostenfrei. </p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20190617","MeetingVerbalixOid":3150,"IdSession":"5018","SpeakerFirstName":"Alain","SpeakerLastName":"Berset","SpeakerFullName":"Berset Alain","SpeakerFunction":"BR-M","CouncilId":99,"CouncilName":"Bundesrat","CantonId":10,"CantonName":"Freiburg","CantonAbbreviation":"FR","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1560784977831)\/","End":"\/Date(1560785067991)\/","Function":"BR-M","DisplaySpeaker":true,"LanguageOfText":"DE","Modified":"\/Date(1774877185318)\/","StartTimeWithTimezone":"\/Date(1560784977830+0120)\/","EndTimeWithTimezone":"\/Date(1560785067990+0120)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"46412","Language":"DE","IdMeeting":"4207","VerbalixOid":593975,"SortOrder":28,"Modified":"\/Date(1774877185314)\/"}}